Biological evaluation of 2′-[18F]fluoroflumazenil ([ 18F]FFMZ), a potential GABA receptor ligand for PET

Nuclear Medicine and Biology

Volumn 31, Issue 2, 2004, Pages 291-295

  Mitterhauser, Markus ^a,b   Wadsak, Wolfgang ^a,c   Wabnegger, Leila ^a   Mien, Leonhard Key ^a   Tögel, Stefan ^a   Langer, Oliver ^a   Sieghart, Werner ^a   Viernstein, Helmut ^a   Kletter, Kurt ^a   Dudczak, Robert ^a,c  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

Author keywords

FFMZ; Flumazenil; Fluoroflumazenil; GABA; PET

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; CARBON 11; FLUMAZENIL; FLUORENE DERIVATIVE; RADIOLIGAND;

ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CEREBELLUM; CONTROLLED STUDY; DRUG ACTIVITY; DRUG BINDING; DRUG POTENCY; DRUG SCREENING; DRUG SYNTHESIS; EVALUATION; FEMALE; GABAERGIC SYSTEM; HYPOPHYSIS; IC 50; IMAGING SYSTEM; INTERMETHOD COMPARISON; ISOTOPE LABELING; MALE; MEMBRANE BINDING; MOLECULAR BIOLOGY; MOLECULAR INTERACTION; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RAT; THALAMUS;

ANIMALS; BRAIN; DRUG EVALUATION, PRECLINICAL; FLUMAZENIL; FLUORINE RADIOISOTOPES; LIGANDS; MALE; METABOLIC CLEARANCE RATE; ORGAN SPECIFICITY; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA; RECEPTORS, GABA-A; TISSUE DISTRIBUTION;

EID: 12144285854     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2003.09.003     Document Type: Article

References (15)

1. A receptor subtypes. Pharmacol Rev. 47:1995;181-234.
2. Nutt D.J., Malizia A.L. New insights into the role of the GABA(A)-benzodiazepine receptor in psychiatric disorder. Br J Psychiatry. 179:2001;390-396.
3. Duncan J.S. Positron emission tomography receptor studies. Adv Neurol. 79:1999;893-899.
4. 11C]methyl-6-oxo-4H-imidazo [1,5-a] [1,4]benzodiazepine-3-carboxylate (Ro 15.1788-11C) a specific radioligand for the in vivo study of central benzodiazepine receptors by positron emission tomography. Int J Appl Radiat Isot. 35:1984;973-976.
5. 18F]fluoroethylflumazenil in rodents. Nucl Med Biol. 28:2001;809-814.
6. 18F]Fluoroethylflumazenil a novel tracer for PET imaging of human benzodiazepine receptors. Eur J Nucl Med. 28:2001;1463-1470.
7. Moerlein S.M., Perlmutter J.S. Binding of 5-(2′-[18F]fluoroethyl) flumazenil to central benzodiazepine receptors measured in living baboon by positron emission tomography. Eur J Pharmacol. 218:1992;109-115.
8. 18F]FETO with respect to the adrenocortical and GABAergic system in rats. Eur J Nucl Med Mol Imaging 2003;30:1398-1401
9. 18F]FETO, a novel potential 11-β hydroxylase inhibitor. J Lab Compd Radpharm. 46:2003;379-388.
10. 18F]FFMZ). J Lab Compd Radpharm 2003;46:1229-1240
11. 18F]fluoroflumazenil (FFMZ) for benzodiazepine receptor imaging. Nucl Med Biol. 30:2003;521-527.
12. Strohle A., Wiedemann K. Flumazenil attenuates the pituitary response to CRH in healthy males. Eur Neuropsychopharmacol. 6:1996;323-325.
13. Berman J.A., Roberts J.L., Pritchett D.B. Molecular and pharmacological characterization of GABAA receptors in the rat pituitary. J Neurochem. 63:1994;1948-1954.
14. A receptors. Neurochem Int. 34:1999;379-385.
15. Areceptors. Trends Pharmacol Sci. 18:1997;425-429.